BioLASCO Taiwan , Ltd.'s inventory is $33M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
BioLASCO Taiwan , Ltd. (6662.TWO) currently reports a inventory of $33M as of June 2026. That compares with $24M in the prior-year period — up 37.0% year over year. Use the charts on this page to explore BioLASCO Taiwan , Ltd.'s inventory history and peer comparisons.
BioLASCO Taiwan , Ltd.'s inventory increased from $24M to $33M — a 37.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
BioLASCO Taiwan , Ltd. reported $33M in inventory as of June 2026. That compares with $24M in the prior-year period — up 37.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current inventory of $33M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioLASCO Taiwan , Ltd., and consider following 6662.TWO for alerts when major investors trade the stock.
BioLASCO Taiwan , Ltd. is classified in the Healthcare sector. On inventory, it currently shows $33M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6662.TWO with unrelated industries.